Literature DB >> 16849340

How do SSRIs help patients with irritable bowel syndrome?

F Creed1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16849340      PMCID： PMC1856284          DOI： 10.1136/gut.2005.086348

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  29 in total

1.  Psychotherapy and paroxetine: cost effective for severe IBS, or a waste of resources.

Authors:  Denesh K Chitkara; Filippo Cremonini; Nicholas J Talley
Journal:  Gastroenterology       Date:  2003-11       Impact factor: 22.682

Review 2.  Selective serotonin reuptake inhibitors for premenstrual syndrome.

Authors:  K M Wyatt; P W Dimmock; P M O'Brien
Journal:  Cochrane Database Syst Rev       Date:  2002

3.  SSRIs in IBS: sensing a dash of disappointment.

Authors:  Nicolas J Talley
Journal:  Clin Gastroenterol Hepatol       Date:  2003-05       Impact factor: 11.382

Review 4.  Antidepressant therapy for unexplained symptoms and symptom syndromes.

Authors:  P G O'Malley; J L Jackson; J Santoro; G Tomkins; E Balden; K Kroenke
Journal:  J Fam Pract       Date:  1999-12       Impact factor: 0.493

Review 5.  Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

Authors:  William E Whitehead; Olafur Palsson; Kenneth R Jones
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

6.  The association of irritable bowel syndrome and somatization disorder.

Authors:  A R Miller; C S North; R E Clouse; R D Wetzel; E L Spitznagel; D H Alpers
Journal:  Ann Clin Psychiatry       Date:  2001-03       Impact factor: 1.567

7.  Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity.

Authors:  J H Atkinson; M A Slater; D R Wahlgren; R A Williams; S Zisook; S D Pruitt; J E Epping-Jordan; T L Patterson; I Grant; I Abramson; S R Garfin
Journal:  Pain       Date:  1999-11       Impact factor: 6.961

8.  Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis.

Authors:  J L Jackson; P G O'Malley; G Tomkins; E Balden; J Santoro; K Kroenke
Journal:  Am J Med       Date:  2000-01       Impact factor: 4.965

9.  A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.

Authors:  J Tack; D Broekaert; B Fischler; L Van Oudenhove; A M Gevers; J Janssens
Journal:  Gut       Date:  2006-01-09       Impact factor: 23.059

10.  The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome.

Authors:  Francis Creed; Lakshmi Fernandes; Elspeth Guthrie; Stephen Palmer; Joy Ratcliffe; Nicholas Read; Christine Rigby; David Thompson; Barbara Tomenson
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682
View more
  10 in total

Review 1.  Psychological approach to managing irritable bowel syndrome.

Authors:  Bu'Hussain Hayee; Ian Forgacs
Journal:  BMJ       Date:  2007-05-26

2.  Psychological Co-morbidity in Functional Gastrointestinal Disorders: Epidemiology, Mechanisms and Management.

Authors:  Justin Cy Wu
Journal:  J Neurogastroenterol Motil       Date:  2012-01-16       Impact factor: 4.924

3.  Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: results from the EPIFUND study.

Authors:  Kate L Holliday; Gary J Macfarlane; Barbara I Nicholl; Francis Creed; Wendy Thomson; John McBeth
Journal:  J Psychosom Res       Date:  2010-05       Impact factor: 3.006

Review 4.  Antidepressants for the treatment of chronic pain.

Authors:  Bénédicte Verdu; Isabelle Decosterd; Thierry Buclin; Friedrich Stiefel; Alexandre Berney
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Early discontinuation of antidepressant treatment and suicide risk among persons aged 50 and over: a population-based register study.

Authors:  Annette Erlangsen; Esben Agerbo; Keith Hawton; Yeates Conwell
Journal:  J Affect Disord       Date:  2009-04-18       Impact factor: 4.839

6.  Age-related response to redeemed antidepressants measured by completed suicide in older adults: a nationwide cohort study.

Authors:  Annette Erlangsen; Yeates Conwell
Journal:  Am J Geriatr Psychiatry       Date:  2013-02-06       Impact factor: 4.105

Review 7.  Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.

Authors:  Lisa Ruepert; A Otto Quartero; Niek J de Wit; Geert J van der Heijden; Gregory Rubin; Jean Wm Muris
Journal:  Cochrane Database Syst Rev       Date:  2011-08-10

8.  Biopsychosocial model of irritable bowel syndrome.

Authors:  Yukari Tanaka; Motoyori Kanazawa; Shin Fukudo; Douglas A Drossman
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

Review 9.  Stress & the gut-brain axis: Regulation by the microbiome.

Authors:  Jane A Foster; Linda Rinaman; John F Cryan
Journal:  Neurobiol Stress       Date:  2017-03-19

10.  Buspirone in the management of refractory irritable bowel syndrome: A case report.

Authors:  Mustafa Abdul Karim; Nadeen Al-Baz; Peter M Haddad; Shuja M Reagu; Majid Alabdulla
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.